Dinh Van Vuong, Suh Yun-Suhk, Yang Han-Kwang, Lim Yong Taik
SKKU Advanced Institute of Nanotechnology, Sungkyunkwan University, Suwon, Republic of Korea.
Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
J Pharm Sci. 2016 Dec;105(12):3634-3644. doi: 10.1016/j.xphs.2016.09.020. Epub 2016 Oct 24.
We report a programed drug delivery system that can tailor the release of anesthetic bupivacaine in a spatiotemporally controlled manner. The drug delivery system was developed through the combination of a collagen-based injectable hydrogel and 2 types of poly(lactic-co-glycolic acid) (PLGA) particles. As a rapid-release platform (90% release after 24 h), bupivacaine hydrochloride was incorporated into collagen/poly(γ-glutamic acid) hydrogel, which exhibited gel formation at body temperature. PLGA microparticles (diameter 1-3 μm) containing bupivacaine base showed a very slow release of bupivacaine (95% after 240 h), whereas PLGA nanoparticles (124 ± 30 nm) containing bupivacaine base demonstrated an intermediate release rate (95% after 160 h). By changing the relative composition ratio between the 3 components in these injectable composite hydrogels, the release of bupivacaine could be easily controlled from very rapid (within 1 day) to very delayed (up to 9 days). The experimental results on the release data (cumulative release, time point release, average release rate) were coincident with the release profile generated by computer simulation. These injectable composite hydrogels with systematically tunable mixing ratios are expected to serve as a promising technology for the on-demand release of bupivacaine in pain management.
我们报道了一种程序性药物递送系统,该系统能够以时空可控的方式定制麻醉剂布比卡因的释放。该药物递送系统是通过将基于胶原蛋白的可注射水凝胶与两种聚乳酸-乙醇酸共聚物(PLGA)颗粒相结合而开发的。作为快速释放平台(24小时后释放90%),盐酸布比卡因被掺入胶原蛋白/聚(γ-谷氨酸)水凝胶中,该水凝胶在体温下会形成凝胶。含有布比卡因碱的PLGA微粒(直径1-3μm)显示布比卡因释放非常缓慢(240小时后释放95%),而含有布比卡因碱的PLGA纳米颗粒(124±30nm)表现出中等释放速率(160小时后释放95%)。通过改变这些可注射复合水凝胶中三种成分之间的相对组成比,布比卡因的释放可以很容易地从非常快速(1天内)控制到非常延迟(长达9天)。关于释放数据(累积释放、时间点释放、平均释放速率)的实验结果与计算机模拟生成的释放曲线一致。这些具有系统可调混合比例的可注射复合水凝胶有望成为疼痛管理中按需释放布比卡因的一项有前景的技术。